<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-16.2'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//www.biotechreality.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://www.biotechreality.com/2026/10/pfizer-litfulo-vitiligo-phase-3-tranquillo-results.html</loc>
  <lastmod>2026-10-03T07:40:48Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Pfizer LITFULO Vitiligo Phase 3 Results: Ritlecitinib Improves Facial and Total Body Repigmentation at EADV</news:title>
   <news:publication_date>2026-10-03T07:40:43Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/10/sanofi-regeneron-alliance-expansion.html</loc>
  <lastmod>2026-10-02T06:24:24Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Sanofi Regeneron Alliance Expansion Adds Four Long-Acting Immunology Antibodies, Including REGN20423, in $1 Billion Upfront Deal</news:title>
   <news:publication_date>2026-10-02T06:24:20Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://www.biotechreality.com/2026/10/abbvie-abbv-295-phase-1-obesity-data.html</loc>
  <lastmod>2026-09-30T19:18:22Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>BiotechReality - Information Intelligence System for Biopharma</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>AbbVie ABBV-295 Phase 1 Data Show Long-Acting Potential for Obesity Treatment at EASD 2026</news:title>
   <news:publication_date>2026-09-30T19:18:18Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
